2
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
20
Other
2
Classical hematology
2
Breast
2
Thoracic
1
NET
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Brain Neoplasms
2306
Glioblastoma
2010
Glioma
1397
Central Nervous System Neoplasms
692
Astrocytoma
667
Neuroblastoma
647
Gliosarcoma
480
Neoplasms
405
Oligodendroglioma
404
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
254
Meningioma
229
Recurrence
223
Sarcoma
214
Melanoma
206
Neoplasm Metastasis
202
Lung Neoplasms
198
Ependymoma
198
Neurofibromatosis 1
169
Lymphoma
161
Meningeal Carcinomatosis
138
Osteosarcoma
134
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
106
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperthyroidism
×
CNS
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled